University of Ottawa
Also known as: Children's Hospital of Eastern Ontario | Children's Hospital of Eastern Ontario (CHEO) Research Institute | Childrens Hospital of Eastern Ontario-Research Inst | Children's Hospital of Eastern Ontario, Research Institute | Children's Hospital of Eastern Ontario, University of Ottawa | Children's Hospital of Western Ontario | Director of Interventional Cardiology - University of Ottawa Heart Institute | Elisabeth Bruyere Hospital and The Ottawa Hospital | Fahad AlKherayf | Head and Chief, Department of Mental Health, The Ottawa Hospital | OHRI | Ottawa Fertility Centre | Ottawa General Hospital Cancer Centre | Ottawa General hospital, Ottawa University, Ottawa, Ontario, Canada | Ottawa Health Research Institute | Ottawa Health Research Institute - General Division | Ottawa Health Research Institute - General Division, Ottawa ON Canada | Ottawa Heart Institute Research Corporation | Ottawa Hospital | Ottawa Hospital and Research Institute | Ottawa Hospital Cancer Centre | Ottawa Hospital General Campus, Canada | Ottawa Hospital, Ottawa Health Research Institute | Ottawa Hospital Research Institute | Ottawa Hospital Research Institute, Bruyere Research Institute | Ottawa Hospital Research Institute / Division of Hematology- The Ottawa Hospital | Ottawa Hospital Research Institute, ON Canada | Ottawa Hospital Research Institute, Ontario, Canada | Ottawa Hospital Research Institute, Ottawa, Canada | Ottawa Hospital Research Institute, Ottawa, ON Canada | Ottawa Regional Cancer Centre | Ottawa University | Psychiatrist at the OSI Clinic at the Royal Ottawa Mental Health Centre | Royal Ottawa Mental Health Centre | Scientific Investigator, OHRI | Senior Scientist, Ottawa Hospital Research Institute | The Ottawa Hospital | The Ottawa Hospital Academic Medical Association | The Ottawa Hospital Cancer Centre | The Ottawa Hospital, Dept of Anesthesia | The Ottawa Hospital Division of Dermatology | The Ottawa Hospital Division of Infectious Diseases | The Ottawa Hospital, On | The Ottawa Hospital, Ottawa Hospital Research Institute | The Ottawa Hospital; Ottawa Hospital Research Institute | The Ottawa Hospital, Ottawa Hospital Research Institute, University of Ottawa | The Ottawa Hospital Regional Cancer Centre | The Ottawa Hospital Research Institute | The Ottawa Hospital Research Institute, University of Ottawa | The Ottawa Hospital, The Ottawa Hospital Research Institute | The Ottawa Hospital, University of Ottawa | The Ottowa Hospital/University of Ottowa | The Royal Ottawa Hospital | The Royal Ottawa Mental Health Centre | The Royal's Institute of Mental Health Research, | The University of Ottawa Heart Insitute | The University of Ottawa Heart Institute, The Ottawa Hospital | Univeristy of Ottawa Heart Institute | University of Ottawa | University of Ottawa at The Ottawa Hospital | University of Ottawa Heart Institiute | University of Ottawa Heart Institute | University of Ottawa Institute of Mental Health Research | University of Ottawa, Institute of Mental Health Research | University of Ottawa, Institute of Mental Health Research - Mood Disorders Research Unit | University of Ottawa / Ottawa Hospital Research Institute,
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1990Last known activity
Dec 15, 2025
Timeline
1840s
- Jan 1, 1848
University of Ottawa— Founded
Drugs by trial phase (327 distinct, 376 trials)
Phase 4 (86 own, 0 via acquisition)
Phase 3 (94 own, 0 via acquisition)
Phase 2 (91 own, 0 via acquisition)
Phase 1 (30 own, 0 via acquisition)
Other trials (26 own, 0 via acquisition)
Indications
Studied for
- Abortion, Spontaneous
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Kidney Injury
- Acute Lung Injury
- Acute Pain
- Adenocarcinoma
- Adenoviridae Infections
- Adrenocortical Carcinoma
- Aggression
- Alzheimer Disease
- Anemia
- Anemia, Iron-Deficiency
- Anorexia
- Anorexia Nervosa
- Anterior Wall Myocardial Infarction
- Antiphospholipid Syndrome
- Anxiety Disorders
- Aortic Valve Stenosis
- Appendicitis
- Arterial Occlusive Diseases
- Arteritis
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Atrophy
- Avitaminosis
- Bipolar Disorder
- Blood Coagulation Disorders
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchiolitis
- Bronchopulmonary Dysplasia
- Cachexia
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cardiac Output, Low
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Cardiotoxicity
- Cardiovascular Diseases
- Carotid Stenosis
- Cellulitis
- Central Nervous System Neoplasms
- Cerebral Infarction
- Cognition Disorders
- Cognitive Dysfunction
- Coinfection
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Communicable Diseases
- Compulsive Personality Disorder
- Congenital Abnormalities
- Constriction, Pathologic
- Coronary Artery Disease
- Coronary Disease
- Coronary Stenosis
- Cough
- Critical Illness
- Cystic Fibrosis
- Delirium
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Dextrocardia
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diarrhea
- Disease
- Disease Progression
- Dystocia
- Embolism
- Embolism and Thrombosis
- Emergencies
- Empyema
- Empyema, Pleural
- Enuresis
- Familial Primary Pulmonary Hypertension
- Febrile Neutropenia
- Feeding and Eating Disorders
- Fetal Death
- Fibrosis
- Gastroenteritis
- Head and Neck Neoplasms
- Heart Defects, Congenital
- Heart Diseases
- Heart Failure
- Hematologic Neoplasms
- Hematoma
- Hemorrhage
- Hemostatic Disorders
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
Recent trials (50)
- NCT07253753OfficialPhase 1Dec 15, 2025
- NCT07237282OfficialPhase 1Dec 1, 2025
- NCT07097012CollaboratorPhase 4Oct 16, 2025
- NCT07058025OfficialPhase 2Oct 1, 2025
- NCT07058025Lead sponsorPhase 2Oct 1, 2025
- NCT07059377Lead sponsorPhase 3Sep 30, 2025
- NCT06983821OfficialPhase 3Aug 31, 2025
- NCT06983821Lead sponsorPhase 3Aug 31, 2025
- NCT06965998Lead sponsorPhase 2/Phase 3Aug 6, 2025
- NCT06965998OfficialPhase 2/Phase 3Aug 6, 2025
- NCT07145736CollaboratorPhase 4Aug 4, 2025
- NCT06884540OfficialN/AJul 15, 2025
- NCT06906068CollaboratorN/AJun 2, 2025
- NCT06907251Lead sponsorPhase 3Jun 1, 2025
- NCT06997796CollaboratorPhase 1/Phase 2May 31, 2025
Details
- Founded
- Ottawa, Ontario, CA Jan 1, 1848
- Last known activity
- Dec 15, 2025